In addition to vitiligo, Mini also works with cancer survivors, helping to reconstruct areolas post-mastectomy, and individuals with burn scars or surgical marks. Her approach is deeply personal, ...

Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on September 24, 2024, the New Drug Application (NDA) for ...

In the JAK/STAT pathway, we currently have some new treatments, topically, to treat vitiligo that have been shown to be very effective, especially on the face, which is, of course, one of the most ...

The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

Ahammune Biosciences, a clinical-stage therapeutics company focused on developing new treatments for skin diseases, has ...

Biotech startup Ahammune Biosciences has raised $5 million in Series A funding round led by pi Ventures. The round also ...

Vitiligo causes patches of skin with lost pigment, but it can also raise your risk of eye and skin damage from UV rays. Find out how new and old treatments may work for your vitiligo.

Keywords: Vitiligo, Artificial Intelligence, Novel Therapies Dermatology, Patient Care, Clinical Research, Diagnostic Tools, Treatment Outcomes, AI in Medicine, Skin Disorders Important Note: All ...

Incyte is preparing to take an oral JAK inhibitor into phase 3 trials for the skin ... “Vitiligo often has a significant impact on patients’ lives, and there is a need for new treatment ...